Park Ha Biological Technology Co. Ltd. has received notifications from Nasdaq regarding its failure to meet requirements related to minimum bid price and market value of listed securities. As of September 2, 2025, the company's ordinary shares have been trading below the necessary $1 per share for 30 consecutive business days, and its market value has fallen below $35 million. The company has until March 2, 2026, to regain compliance. If it fails to do so, it may qualify for an additional 180-day compliance period to address these deficiencies, potentially through measures such as a reverse stock split. Currently, there are no immediate effects on its listing or trading status.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Park Ha Biological Technology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-084997), on September 05, 2025, and is solely responsible for the information contained therein.